GHK-Cu (Copper Peptide)

Research GHK-Cu and Cosmetic Copper Peptides Compared

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides2 min readLast reviewed 2026-08-233 cited sources

The short answer

Cosmetic copper peptide products contain copper tripeptide-1 formulated into a topical base, regulated as cosmetics and sold for appearance claims. Research material is unformulated compound supplied for laboratory use under no such framework. Same molecule, entirely different products and regulation.

Key facts

Cosmetic product
Formulated topical, regulated as a cosmetic
Research material
Unformulated, laboratory use only
Shared
The same molecule
Cosmetic concentration
Formulated and disclosed by the maker
Permitted cosmetic claims
Appearance only
Research material claims
None permitted

What a cosmetic product is

A finished cosmetic is a formulation: the active ingredient plus a vehicle, preservative system, stabilisers and whatever else is needed to make it usable and shelf-stable. Formulation is most of the work, and for a metal complex it is difficult. The base has to maintain the pH range the complex needs and avoid chelating agents that would strip its copper.

What research material is

Unformulated compound. There is no vehicle, no preservative system and no stability work relating it to any particular use. It is supplied to be dissolved and used in laboratory work, and its specification describes identity and purity rather than performance in a product.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

Two regulatory frameworks

Cosmetics regulation governs safety assessment, ingredient restrictions, labelling and permissible claims for finished products sold to consumers. Research material sits outside it entirely. This is not because it is unregulated, but because it is supplied for a different purpose under a different basis. Neither framework converts into the other.

The formulation problem, specifically

GHK-Cu's copper is reversibly bound and its stability depends on pH and the absence of competing chelators. Many common cosmetic bases contain chelators as stabilisers, and pH is dictated by other formulation requirements. Getting a stable copper peptide product is therefore a real technical achievement rather than a matter of adding the ingredient, which is a reason to be sceptical of any assumption that unformulated compound behaves like a finished product.

The inference not to make

That because copper peptides appear in cosmetic products, research material can be used the same way. It cannot. Research material is supplied for laboratory use, carries no formulation, no safety assessment for topical use and no permitted claims. The presence of a molecule in a regulated consumer product says nothing about the appropriate use of the same molecule supplied unformulated.

Frequently asked questions

Is it the same molecule?
Yes. What differs is formulation, regulatory framework, permitted claims and intended use.
Why is formulating copper peptides difficult?
The copper is reversibly bound and sensitive to pH and competing chelators, both of which are constrained by other formulation requirements.
Can research material be used like a cosmetic?
No. It is unformulated, has no safety assessment for that use, and is supplied for laboratory research only.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

  • ▸In vitro fibroblast and keratinocyte gene-expression studies
  • ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
  • ▸Wound-healing scratch assays in cell culture models
  • ▸Antioxidant-mechanism studies (copper redox modulation)
  • ▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

  • ✓Store lyophilised vial at 2–8 °C, protected from light
  • ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
  • ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
  • ✓Aliquot reconstituted solution for freeze/thaw minimisation
  • ✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.